Effects of Sea Buckthorn Oil on Dry Eye (DESB)
Recruitment status was Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The objective is to study the effect of sea buckthorn oil on dry eye.
| Condition | Intervention |
|---|---|
|
Dry Eye Syndromes |
Dietary Supplement: Sea buckthorn (Hippophaë rhamnoides) oil Dietary Supplement: Placebo comparison |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Effects of Sea Buckthorn Oil on Dry Eye |
- Symptom severity: symptom questionnaires and clinical dry eye tests [ Time Frame: 3 months intervention + 1 month after the intervention ] [ Designated as safety issue: Yes ]
- Tear film lipid profile, tear cytokines, inflammation mediators in blood [ Time Frame: 3 months intervention + 1 month after the intervention ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 80 |
| Study Start Date: | September 2008 |
| Estimated Study Completion Date: | March 2009 |
| Estimated Primary Completion Date: | March 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: SB
Sea buckthorn oil group
|
Dietary Supplement: Sea buckthorn (Hippophaë rhamnoides) oil
Dosage 2 g/d, frequency twice/d, duration 3 months
|
|
Placebo Comparator: PL
Placebo group
|
Dietary Supplement: Placebo comparison
Placebo comparison, dosage 2 g/d, frequency twice/d, duration 3 months
|
Detailed Description:
The objective is to study whether regular consumption of sea buckthorn berry oil can relieve the symptoms of dry eye syndrome. The study design is a parallel randomized double-blind placebo controlled trial. The participants daily consume sea buckthorn or placebo oil for 3 months. The dry eye symptoms will be monitored during the study using a validated questionnaire. In addition clinical dry eye tests are made by an ophthalmologist three time during the study. Samples will be taken for tear film lipid and cytokine analyses. Blood samples for the analyses of inflammatory markers are also obtained. The cytokine and other inflammation marker analyses are optional. The symptoms will be monitored and clinical tests made also 4 weeks after the participants have stopped consuming the study oils.
Eligibility| Ages Eligible for Study: | 20 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Dry eye symptoms
Exclusion Criteria:
- Severe illness
- Anticholinergic drugs
- Smoking
Contacts and Locations| Finland | |
| University of Turku | |
| Turku, Finland, 20014 | |
| Study Director: | Heikki P Kallio, Professor | University of Turku |
More Information
Publications:
| Responsible Party: | Matti Viitanen/ Professor, University of Turku |
| ClinicalTrials.gov Identifier: | NCT00739713 History of Changes |
| Other Study ID Numbers: | DESB |
| Study First Received: | August 21, 2008 |
| Last Updated: | June 24, 2010 |
| Health Authority: | Finland: Ethics Committee |
Keywords provided by University of Turku:
|
dry eye sea buckthorn Hippophaë |
Additional relevant MeSH terms:
|
Dry Eye Syndromes Keratoconjunctivitis Sicca Lacrimal Apparatus Diseases Eye Diseases Keratoconjunctivitis |
Conjunctivitis Conjunctival Diseases Keratitis Corneal Diseases |
ClinicalTrials.gov processed this record on May 19, 2013